NCT03550365

Brief Summary

Wholegrain fibre is known to affect on the gut health, but also may cause intestinal discomfort. Thus, many individuals may avoid the consumption of whole grain cereals in spite of their known health benefits, and may in this regard consume more restricted diets. In the preset study the aim was to technologically modify the cereal fibres to improve its usability and to maintain its health beneficial properties. The objective was to investigate intestinal fermentation of grain dietary fibre and associated effects on gut-mediated metabolic health, such as immunological health and adipose tissue function. The hypothesis was that whole grain products maintain their original beneficial health effects and may be better tolerable when the bran is technologically modified. Additionally, it was hypothesized that gut-mediated bioavailability of plant cell wall compounds and their metabolites affect the metabolic health through their immunomodulatory effects.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2011

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2012

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 14, 2018

Completed
25 days until next milestone

First Posted

Study publicly available on registry

June 8, 2018

Completed
Last Updated

June 20, 2018

Status Verified

June 1, 2018

Enrollment Period

2 years

First QC Date

May 14, 2018

Last Update Submit

June 18, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • gastrointestinal symptoms

    intestinal discomfort measured by questionnaire

    4 week dietary period

Secondary Outcomes (8)

  • Glucose concentration

    4 week dietary period

  • Insulin concentration

    4 week dietary period

  • fecal microbiota

    4 week dietary period

  • Exhaled air

    4 week dietary period

  • highly sensitive C-reactive protein

    4 week dietary period

  • +3 more secondary outcomes

Study Arms (3)

Rye bran bread intervention

EXPERIMENTAL

4 week rye bran bread diet intervention with dietary fibre intake of 30g

Other: Rye bran bread intervention

Rye bread intervention

EXPERIMENTAL

4 week rye bread diet intervention with dietary fibre intake of 30g

Other: Rye bread intervention

Wheat bread intervention

ACTIVE COMPARATOR

4 week wheat bread diet intervention with dietary fibre intake of 5-20g prior to two other arms

Other: Wheat bread diet

Interventions

4 week dietary intervention rich in rye bran bread

Rye bran bread intervention

4 week dietary intervention rich in rye bread

Rye bread intervention

4 week dietary intervention rich in wheat bread as an active comparator for previous two interventions

Wheat bread intervention

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI 23-30 kg/m2
  • abdominally obese (waist circumference \>90 cm (men)/ \>80 cm (women))
  • gastrointestinal symptoms

You may not qualify if:

  • celiac diseases
  • extended allergies
  • exceptional diets
  • IBD patients
  • recent (2 mo) use of antibiotic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Lappi J, Mykkanen H, Bach Knudsen KE, Kirjavainen P, Katina K, Pihlajamaki J, Poutanen K, Kolehmainen M. Postprandial glucose metabolism and SCFA after consuming wholegrain rye bread and wheat bread enriched with bioprocessed rye bran in individuals with mild gastrointestinal symptoms. Nutr J. 2014 Nov 4;13:104. doi: 10.1186/1475-2891-13-104.

  • Lappi J, Aura AM, Katina K, Nordlund E, Kolehmainen M, Mykkanen H, Poutanen K. Comparison of postprandial phenolic acid excretions and glucose responses after ingestion of breads with bioprocessed or native rye bran. Food Funct. 2013 Jun;4(6):972-81. doi: 10.1039/c3fo60078e. Epub 2013 May 14.

  • Raninen K, Lappi J, Kolehmainen M, Kolehmainen M, Mykkanen H, Poutanen K, Raatikainen O. Diet-derived changes by sourdough-fermented rye bread in exhaled breath aspiration ion mobility spectrometry profiles in individuals with mild gastrointestinal symptoms. Int J Food Sci Nutr. 2017 Dec;68(8):987-996. doi: 10.1080/09637486.2017.1312296. Epub 2017 Apr 9.

  • Keski-Rahkonen P, Kolehmainen M, Lappi J, Micard V, Jokkala J, Rosa-Sibakov N, Pihlajamaki J, Kirjavainen PV, Mykkanen H, Poutanen K, Gunter MJ, Scalbert A, Hanhineva K. Decreased plasma serotonin and other metabolite changes in healthy adults after consumption of wholegrain rye: an untargeted metabolomics study. Am J Clin Nutr. 2019 Jun 1;109(6):1630-1639. doi: 10.1093/ajcn/nqy394.

MeSH Terms

Conditions

Intestinal DiseasesGlucose Metabolism DisordersInflammation

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Marjukka Kolehmainen, Professor

    University of Eastern Finland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 14, 2018

First Posted

June 8, 2018

Study Start

January 1, 2011

Primary Completion

December 31, 2012

Study Completion

December 31, 2017

Last Updated

June 20, 2018

Record last verified: 2018-06